nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Warmth—Niacin—atherosclerosis	0.0299	0.0446	CcSEcCtD
Nalbuphine—Laryngeal oedema—Niacin—atherosclerosis	0.0148	0.0221	CcSEcCtD
Nalbuphine—Redness—Niacin—atherosclerosis	0.0141	0.021	CcSEcCtD
Nalbuphine—Naloxone—TLR4—atherosclerosis	0.0133	0.711	CrCbGaD
Nalbuphine—Feeling hot—Niacin—atherosclerosis	0.0121	0.0181	CcSEcCtD
Nalbuphine—Tingling sensation—Niacin—atherosclerosis	0.0118	0.0176	CcSEcCtD
Nalbuphine—Numbness—Pravastatin—atherosclerosis	0.0113	0.0168	CcSEcCtD
Nalbuphine—Sensory loss—Pravastatin—atherosclerosis	0.0108	0.0161	CcSEcCtD
Nalbuphine—Swelling—Simvastatin—atherosclerosis	0.00852	0.0127	CcSEcCtD
Nalbuphine—Depression—Rosuvastatin—atherosclerosis	0.00729	0.0109	CcSEcCtD
Nalbuphine—Cramp muscle—Lovastatin—atherosclerosis	0.00724	0.0108	CcSEcCtD
Nalbuphine—Cramp muscle—Ezetimibe—atherosclerosis	0.0071	0.0106	CcSEcCtD
Nalbuphine—Cramp muscle—Simvastatin—atherosclerosis	0.00677	0.0101	CcSEcCtD
Nalbuphine—Cramp muscle—Pravastatin—atherosclerosis	0.00612	0.00913	CcSEcCtD
Nalbuphine—Depression—Simvastatin—atherosclerosis	0.00578	0.00862	CcSEcCtD
Nalbuphine—Sweating increased—Pravastatin—atherosclerosis	0.00572	0.00854	CcSEcCtD
Nalbuphine—Depression—Pravastatin—atherosclerosis	0.00522	0.00779	CcSEcCtD
Nalbuphine—Flushing—Lovastatin—atherosclerosis	0.00516	0.0077	CcSEcCtD
Nalbuphine—Flushing—Ezetimibe—atherosclerosis	0.00506	0.00755	CcSEcCtD
Nalbuphine—Flushing—Simvastatin—atherosclerosis	0.00483	0.0072	CcSEcCtD
Nalbuphine—Hypoaesthesia—Niacin—atherosclerosis	0.00475	0.00709	CcSEcCtD
Nalbuphine—Erythema—Ezetimibe—atherosclerosis	0.00475	0.00708	CcSEcCtD
Nalbuphine—Dysgeusia—Lovastatin—atherosclerosis	0.00474	0.00707	CcSEcCtD
Nalbuphine—Confusional state—Rosuvastatin—atherosclerosis	0.0047	0.00701	CcSEcCtD
Nalbuphine—Hypoaesthesia—Pravastatin—atherosclerosis	0.00468	0.00698	CcSEcCtD
Nalbuphine—Muscle spasms—Lovastatin—atherosclerosis	0.00465	0.00694	CcSEcCtD
Nalbuphine—Muscle spasms—Ezetimibe—atherosclerosis	0.00457	0.00681	CcSEcCtD
Nalbuphine—Vision blurred—Lovastatin—atherosclerosis	0.00456	0.0068	CcSEcCtD
Nalbuphine—Tremor—Lovastatin—atherosclerosis	0.00454	0.00676	CcSEcCtD
Nalbuphine—Erythema—Simvastatin—atherosclerosis	0.00453	0.00675	CcSEcCtD
Nalbuphine—Dysgeusia—Simvastatin—atherosclerosis	0.00443	0.00661	CcSEcCtD
Nalbuphine—Flushing—Niacin—atherosclerosis	0.00443	0.00661	CcSEcCtD
Nalbuphine—Flushing—Pravastatin—atherosclerosis	0.00436	0.00651	CcSEcCtD
Nalbuphine—Muscle spasms—Simvastatin—atherosclerosis	0.00435	0.00649	CcSEcCtD
Nalbuphine—Vertigo—Lovastatin—atherosclerosis	0.00435	0.00649	CcSEcCtD
Nalbuphine—Vision blurred—Simvastatin—atherosclerosis	0.00427	0.00636	CcSEcCtD
Nalbuphine—Tremor—Simvastatin—atherosclerosis	0.00424	0.00633	CcSEcCtD
Nalbuphine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00419	0.00624	CcSEcCtD
Nalbuphine—Erythema—Niacin—atherosclerosis	0.00416	0.0062	CcSEcCtD
Nalbuphine—Anxiety—Lovastatin—atherosclerosis	0.00411	0.00613	CcSEcCtD
Nalbuphine—Dyspepsia—Rosuvastatin—atherosclerosis	0.0041	0.00612	CcSEcCtD
Nalbuphine—Hypertension—Ezetimibe—atherosclerosis	0.0041	0.00611	CcSEcCtD
Nalbuphine—Tension—Niacin—atherosclerosis	0.00408	0.00609	CcSEcCtD
Nalbuphine—Vertigo—Simvastatin—atherosclerosis	0.00407	0.00607	CcSEcCtD
Nalbuphine—Nervousness—Niacin—atherosclerosis	0.00404	0.00602	CcSEcCtD
Nalbuphine—Dry mouth—Lovastatin—atherosclerosis	0.00403	0.00601	CcSEcCtD
Nalbuphine—Tension—Pravastatin—atherosclerosis	0.00402	0.00599	CcSEcCtD
Nalbuphine—Dysgeusia—Pravastatin—atherosclerosis	0.00401	0.00598	CcSEcCtD
Nalbuphine—Muscle spasms—Niacin—atherosclerosis	0.004	0.00596	CcSEcCtD
Nalbuphine—Confusional state—Lovastatin—atherosclerosis	0.00398	0.00594	CcSEcCtD
Nalbuphine—Nervousness—Pravastatin—atherosclerosis	0.00398	0.00593	CcSEcCtD
Nalbuphine—Dry mouth—Ezetimibe—atherosclerosis	0.00395	0.0059	CcSEcCtD
Nalbuphine—Muscle spasms—Pravastatin—atherosclerosis	0.00394	0.00587	CcSEcCtD
Nalbuphine—Vision blurred—Niacin—atherosclerosis	0.00392	0.00584	CcSEcCtD
Nalbuphine—Confusional state—Ezetimibe—atherosclerosis	0.00391	0.00583	CcSEcCtD
Nalbuphine—Vision blurred—Pravastatin—atherosclerosis	0.00386	0.00575	CcSEcCtD
Nalbuphine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00384	0.00573	CcSEcCtD
Nalbuphine—Anxiety—Simvastatin—atherosclerosis	0.00384	0.00573	CcSEcCtD
Nalbuphine—Tremor—Pravastatin—atherosclerosis	0.00384	0.00572	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00381	0.00569	CcSEcCtD
Nalbuphine—Vertigo—Niacin—atherosclerosis	0.00374	0.00557	CcSEcCtD
Nalbuphine—Naloxone—ESR1—atherosclerosis	0.00373	0.2	CrCbGaD
Nalbuphine—Syncope—Niacin—atherosclerosis	0.00373	0.00556	CcSEcCtD
Nalbuphine—Confusional state—Simvastatin—atherosclerosis	0.00373	0.00556	CcSEcCtD
Nalbuphine—Urticaria—Rosuvastatin—atherosclerosis	0.0037	0.00552	CcSEcCtD
Nalbuphine—Oedema—Simvastatin—atherosclerosis	0.0037	0.00551	CcSEcCtD
Nalbuphine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00369	0.0055	CcSEcCtD
Nalbuphine—Vertigo—Pravastatin—atherosclerosis	0.00368	0.00549	CcSEcCtD
Nalbuphine—Loss of consciousness—Niacin—atherosclerosis	0.00365	0.00545	CcSEcCtD
Nalbuphine—Paraesthesia—Lovastatin—atherosclerosis	0.00355	0.00529	CcSEcCtD
Nalbuphine—Hypertension—Pravastatin—atherosclerosis	0.00353	0.00527	CcSEcCtD
Nalbuphine—Dyspnoea—Lovastatin—atherosclerosis	0.00352	0.00525	CcSEcCtD
Nalbuphine—Paraesthesia—Ezetimibe—atherosclerosis	0.00348	0.00519	CcSEcCtD
Nalbuphine—Dyspepsia—Lovastatin—atherosclerosis	0.00348	0.00519	CcSEcCtD
Nalbuphine—Anxiety—Pravastatin—atherosclerosis	0.00347	0.00518	CcSEcCtD
Nalbuphine—Dry mouth—Niacin—atherosclerosis	0.00346	0.00516	CcSEcCtD
Nalbuphine—Dyspnoea—Ezetimibe—atherosclerosis	0.00345	0.00515	CcSEcCtD
Nalbuphine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00343	0.00512	CcSEcCtD
Nalbuphine—Dyspepsia—Ezetimibe—atherosclerosis	0.00341	0.00509	CcSEcCtD
Nalbuphine—Oedema—Niacin—atherosclerosis	0.00339	0.00506	CcSEcCtD
Nalbuphine—Confusional state—Pravastatin—atherosclerosis	0.00337	0.00502	CcSEcCtD
Nalbuphine—Asthenia—Rosuvastatin—atherosclerosis	0.00335	0.00499	CcSEcCtD
Nalbuphine—Oedema—Pravastatin—atherosclerosis	0.00334	0.00498	CcSEcCtD
Nalbuphine—Shock—Niacin—atherosclerosis	0.00334	0.00498	CcSEcCtD
Nalbuphine—Paraesthesia—Simvastatin—atherosclerosis	0.00332	0.00495	CcSEcCtD
Nalbuphine—Tachycardia—Niacin—atherosclerosis	0.00331	0.00494	CcSEcCtD
Nalbuphine—Pruritus—Rosuvastatin—atherosclerosis	0.0033	0.00492	CcSEcCtD
Nalbuphine—Dyspnoea—Simvastatin—atherosclerosis	0.00329	0.00491	CcSEcCtD
Nalbuphine—Hyperhidrosis—Niacin—atherosclerosis	0.00328	0.00489	CcSEcCtD
Nalbuphine—Feeling abnormal—Lovastatin—atherosclerosis	0.00326	0.00486	CcSEcCtD
Nalbuphine—Dyspepsia—Simvastatin—atherosclerosis	0.00325	0.00485	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00323	0.00482	CcSEcCtD
Nalbuphine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00323	0.00482	CcSEcCtD
Nalbuphine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00319	0.00476	CcSEcCtD
Nalbuphine—Hypotension—Niacin—atherosclerosis	0.00317	0.00473	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00317	0.00473	CcSEcCtD
Nalbuphine—Urticaria—Lovastatin—atherosclerosis	0.00314	0.00468	CcSEcCtD
Nalbuphine—Abdominal pain—Lovastatin—atherosclerosis	0.00312	0.00466	CcSEcCtD
Nalbuphine—Body temperature increased—Lovastatin—atherosclerosis	0.00312	0.00466	CcSEcCtD
Nalbuphine—Dizziness—Rosuvastatin—atherosclerosis	0.00308	0.0046	CcSEcCtD
Nalbuphine—Urticaria—Ezetimibe—atherosclerosis	0.00308	0.00459	CcSEcCtD
Nalbuphine—Body temperature increased—Ezetimibe—atherosclerosis	0.00306	0.00457	CcSEcCtD
Nalbuphine—Abdominal pain—Ezetimibe—atherosclerosis	0.00306	0.00457	CcSEcCtD
Nalbuphine—Paraesthesia—Niacin—atherosclerosis	0.00305	0.00454	CcSEcCtD
Nalbuphine—Feeling abnormal—Simvastatin—atherosclerosis	0.00305	0.00454	CcSEcCtD
Nalbuphine—Dyspnoea—Niacin—atherosclerosis	0.00303	0.00451	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00302	0.00451	CcSEcCtD
Nalbuphine—Somnolence—Niacin—atherosclerosis	0.00302	0.0045	CcSEcCtD
Nalbuphine—Paraesthesia—Pravastatin—atherosclerosis	0.003	0.00447	CcSEcCtD
Nalbuphine—Dyspepsia—Niacin—atherosclerosis	0.00299	0.00445	CcSEcCtD
Nalbuphine—Dyspnoea—Pravastatin—atherosclerosis	0.00298	0.00444	CcSEcCtD
Nalbuphine—Dyspepsia—Pravastatin—atherosclerosis	0.00294	0.00439	CcSEcCtD
Nalbuphine—Rash—Rosuvastatin—atherosclerosis	0.00294	0.00438	CcSEcCtD
Nalbuphine—Dermatitis—Rosuvastatin—atherosclerosis	0.00294	0.00438	CcSEcCtD
Nalbuphine—Urticaria—Simvastatin—atherosclerosis	0.00294	0.00438	CcSEcCtD
Nalbuphine—Abdominal pain—Simvastatin—atherosclerosis	0.00292	0.00436	CcSEcCtD
Nalbuphine—Body temperature increased—Simvastatin—atherosclerosis	0.00292	0.00436	CcSEcCtD
Nalbuphine—Headache—Rosuvastatin—atherosclerosis	0.00292	0.00436	CcSEcCtD
Nalbuphine—Hypersensitivity—Lovastatin—atherosclerosis	0.00291	0.00434	CcSEcCtD
Nalbuphine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00286	0.00426	CcSEcCtD
Nalbuphine—Asthenia—Lovastatin—atherosclerosis	0.00283	0.00423	CcSEcCtD
Nalbuphine—Pruritus—Lovastatin—atherosclerosis	0.0028	0.00417	CcSEcCtD
Nalbuphine—Asthenia—Ezetimibe—atherosclerosis	0.00278	0.00415	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Niacin—atherosclerosis	0.00277	0.00414	CcSEcCtD
Nalbuphine—Nausea—Rosuvastatin—atherosclerosis	0.00277	0.00413	CcSEcCtD
Nalbuphine—Feeling abnormal—Pravastatin—atherosclerosis	0.00275	0.00411	CcSEcCtD
Nalbuphine—Pruritus—Ezetimibe—atherosclerosis	0.00274	0.00409	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00273	0.00407	CcSEcCtD
Nalbuphine—Hypersensitivity—Simvastatin—atherosclerosis	0.00272	0.00406	CcSEcCtD
Nalbuphine—Urticaria—Niacin—atherosclerosis	0.0027	0.00402	CcSEcCtD
Nalbuphine—Body temperature increased—Niacin—atherosclerosis	0.00268	0.004	CcSEcCtD
Nalbuphine—Abdominal pain—Niacin—atherosclerosis	0.00268	0.004	CcSEcCtD
Nalbuphine—Urticaria—Pravastatin—atherosclerosis	0.00265	0.00396	CcSEcCtD
Nalbuphine—Asthenia—Simvastatin—atherosclerosis	0.00265	0.00395	CcSEcCtD
Nalbuphine—Body temperature increased—Pravastatin—atherosclerosis	0.00264	0.00394	CcSEcCtD
Nalbuphine—Abdominal pain—Pravastatin—atherosclerosis	0.00264	0.00394	CcSEcCtD
Nalbuphine—Pruritus—Simvastatin—atherosclerosis	0.00261	0.0039	CcSEcCtD
Nalbuphine—Dizziness—Lovastatin—atherosclerosis	0.00261	0.0039	CcSEcCtD
Nalbuphine—Dizziness—Ezetimibe—atherosclerosis	0.00256	0.00382	CcSEcCtD
Nalbuphine—Vomiting—Lovastatin—atherosclerosis	0.00251	0.00375	CcSEcCtD
Nalbuphine—Hypersensitivity—Niacin—atherosclerosis	0.0025	0.00373	CcSEcCtD
Nalbuphine—Rash—Lovastatin—atherosclerosis	0.00249	0.00372	CcSEcCtD
Nalbuphine—Dermatitis—Lovastatin—atherosclerosis	0.00249	0.00371	CcSEcCtD
Nalbuphine—Headache—Lovastatin—atherosclerosis	0.00248	0.00369	CcSEcCtD
Nalbuphine—Vomiting—Ezetimibe—atherosclerosis	0.00246	0.00367	CcSEcCtD
Nalbuphine—Hypersensitivity—Pravastatin—atherosclerosis	0.00246	0.00367	CcSEcCtD
Nalbuphine—Dizziness—Simvastatin—atherosclerosis	0.00244	0.00364	CcSEcCtD
Nalbuphine—Rash—Ezetimibe—atherosclerosis	0.00244	0.00364	CcSEcCtD
Nalbuphine—Dermatitis—Ezetimibe—atherosclerosis	0.00244	0.00364	CcSEcCtD
Nalbuphine—Asthenia—Niacin—atherosclerosis	0.00243	0.00363	CcSEcCtD
Nalbuphine—Headache—Ezetimibe—atherosclerosis	0.00243	0.00362	CcSEcCtD
Nalbuphine—Pruritus—Niacin—atherosclerosis	0.0024	0.00358	CcSEcCtD
Nalbuphine—Asthenia—Pravastatin—atherosclerosis	0.0024	0.00358	CcSEcCtD
Nalbuphine—Pruritus—Pravastatin—atherosclerosis	0.00236	0.00353	CcSEcCtD
Nalbuphine—Vomiting—Simvastatin—atherosclerosis	0.00235	0.0035	CcSEcCtD
Nalbuphine—Nausea—Lovastatin—atherosclerosis	0.00235	0.0035	CcSEcCtD
Nalbuphine—Rash—Simvastatin—atherosclerosis	0.00233	0.00348	CcSEcCtD
Nalbuphine—Dermatitis—Simvastatin—atherosclerosis	0.00233	0.00347	CcSEcCtD
Nalbuphine—Headache—Simvastatin—atherosclerosis	0.00232	0.00345	CcSEcCtD
Nalbuphine—Nausea—Ezetimibe—atherosclerosis	0.0023	0.00343	CcSEcCtD
Nalbuphine—Dizziness—Niacin—atherosclerosis	0.00224	0.00335	CcSEcCtD
Nalbuphine—Dizziness—Pravastatin—atherosclerosis	0.00221	0.0033	CcSEcCtD
Nalbuphine—Nausea—Simvastatin—atherosclerosis	0.0022	0.00327	CcSEcCtD
Nalbuphine—Vomiting—Niacin—atherosclerosis	0.00216	0.00322	CcSEcCtD
Nalbuphine—Rash—Niacin—atherosclerosis	0.00214	0.00319	CcSEcCtD
Nalbuphine—Dermatitis—Niacin—atherosclerosis	0.00214	0.00319	CcSEcCtD
Nalbuphine—Headache—Niacin—atherosclerosis	0.00213	0.00317	CcSEcCtD
Nalbuphine—Vomiting—Pravastatin—atherosclerosis	0.00212	0.00317	CcSEcCtD
Nalbuphine—Rash—Pravastatin—atherosclerosis	0.00211	0.00314	CcSEcCtD
Nalbuphine—Dermatitis—Pravastatin—atherosclerosis	0.0021	0.00314	CcSEcCtD
Nalbuphine—Headache—Pravastatin—atherosclerosis	0.00209	0.00312	CcSEcCtD
Nalbuphine—Nausea—Niacin—atherosclerosis	0.00202	0.00301	CcSEcCtD
Nalbuphine—Nausea—Pravastatin—atherosclerosis	0.00198	0.00296	CcSEcCtD
Nalbuphine—Naloxone—ALB—atherosclerosis	0.00166	0.0888	CrCbGaD
Nalbuphine—OPRK1—Signaling by GPCR—EDNRA—atherosclerosis	0.000336	0.00108	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR2—atherosclerosis	0.000336	0.00108	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000335	0.00108	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—AGT—atherosclerosis	0.000331	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KNG1—atherosclerosis	0.000328	0.00106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GHRL—atherosclerosis	0.000328	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—UTS2—atherosclerosis	0.000327	0.00105	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGTR1—atherosclerosis	0.000326	0.00105	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCL2—atherosclerosis	0.000323	0.00104	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL4—atherosclerosis	0.000321	0.00103	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—KNG1—atherosclerosis	0.000317	0.00102	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000315	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000314	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CX3CR1—atherosclerosis	0.000313	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASR—atherosclerosis	0.000313	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000313	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000313	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CX3CL1—atherosclerosis	0.000307	0.000988	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—F2—atherosclerosis	0.000306	0.000985	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000305	0.000981	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—EDN1—atherosclerosis	0.000304	0.000979	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCL5—atherosclerosis	0.000302	0.000972	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA2—atherosclerosis	0.0003	0.000966	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA4—atherosclerosis	0.000295	0.000949	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CNR2—atherosclerosis	0.000291	0.000937	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—atherosclerosis	0.000291	0.000936	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MMP3—atherosclerosis	0.00029	0.000935	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KNG1—atherosclerosis	0.000287	0.000925	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000287	0.000924	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—UTS2—atherosclerosis	0.000286	0.000922	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGTR1—atherosclerosis	0.000286	0.00092	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.000284	0.000914	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR2—atherosclerosis	0.000284	0.000914	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000283	0.000911	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GHRL—atherosclerosis	0.000277	0.000891	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EDN1—atherosclerosis	0.000276	0.000889	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CX3CR1—atherosclerosis	0.000275	0.000884	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASR—atherosclerosis	0.000275	0.000884	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL5—atherosclerosis	0.000274	0.000882	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000273	0.000878	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL4—atherosclerosis	0.000272	0.000874	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CX3CL1—atherosclerosis	0.000269	0.000867	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000268	0.000861	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—EDN1—atherosclerosis	0.000267	0.000859	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000266	0.000856	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCL5—atherosclerosis	0.000265	0.000852	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PRKCG—atherosclerosis	0.000261	0.000839	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VWF—atherosclerosis	0.00026	0.000835	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOC3—atherosclerosis	0.000258	0.00083	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LDLR—atherosclerosis	0.000256	0.000825	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CNR2—atherosclerosis	0.000255	0.000822	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—atherosclerosis	0.000255	0.000821	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MMP3—atherosclerosis	0.000255	0.00082	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA2—atherosclerosis	0.000254	0.000817	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000253	0.000813	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000252	0.00081	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL3—atherosclerosis	0.00025	0.000806	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000243	0.000782	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EDN1—atherosclerosis	0.000242	0.00078	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—UTS2—atherosclerosis	0.000242	0.000779	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000242	0.000777	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL5—atherosclerosis	0.00024	0.000774	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NCF1—atherosclerosis	0.00024	0.000772	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—F2—atherosclerosis	0.000233	0.000751	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000232	0.000747	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASR—atherosclerosis	0.000232	0.000747	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGT—atherosclerosis	0.000229	0.000738	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PRKCG—atherosclerosis	0.000229	0.000735	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000228	0.000732	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VWF—atherosclerosis	0.000228	0.000732	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR2—atherosclerosis	0.000226	0.000729	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000226	0.000729	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOC3—atherosclerosis	0.000226	0.000728	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000225	0.000726	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CYBA—atherosclerosis	0.000225	0.000725	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LDLR—atherosclerosis	0.000225	0.000723	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000224	0.00072	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000223	0.000719	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGT—atherosclerosis	0.000221	0.000713	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLAT—atherosclerosis	0.000221	0.00071	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GHRL—atherosclerosis	0.000221	0.00071	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PARP1—atherosclerosis	0.000221	0.00071	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL3—atherosclerosis	0.00022	0.000706	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CNR2—atherosclerosis	0.000216	0.000694	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000216	0.000694	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000215	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000213	0.000685	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—F2—atherosclerosis	0.000212	0.000682	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NCF1—atherosclerosis	0.00021	0.000677	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000205	0.000659	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—F2—atherosclerosis	0.000205	0.000658	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000203	0.000654	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000203	0.000653	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGT—atherosclerosis	0.000201	0.000647	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	0.000199	0.000639	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR2—atherosclerosis	0.000199	0.000639	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CYBA—atherosclerosis	0.000198	0.000636	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000196	0.00063	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KNG1—atherosclerosis	0.000194	0.000623	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GHRL—atherosclerosis	0.000193	0.000623	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLAT—atherosclerosis	0.000193	0.000623	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PARP1—atherosclerosis	0.000193	0.000623	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000193	0.000622	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000193	0.00062	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VWF—atherosclerosis	0.000192	0.000619	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOC3—atherosclerosis	0.000191	0.000615	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LDLR—atherosclerosis	0.00019	0.000611	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	0.000189	0.000608	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLG—atherosclerosis	0.000188	0.000604	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000187	0.000602	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—F2—atherosclerosis	0.000186	0.000598	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL3—atherosclerosis	0.000186	0.000597	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000178	0.000572	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NCF1—atherosclerosis	0.000178	0.000572	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000178	0.000572	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—F2—atherosclerosis	0.000173	0.000556	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP3—atherosclerosis	0.000172	0.000552	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF2—atherosclerosis	0.000171	0.00055	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGT—atherosclerosis	0.00017	0.000547	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KNG1—atherosclerosis	0.00017	0.000546	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	0.000169	0.000543	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR2—atherosclerosis	0.000168	0.00054	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000168	0.00054	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CYBA—atherosclerosis	0.000167	0.000538	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOB—atherosclerosis	0.000166	0.000534	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	0.000166	0.000533	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000166	0.000533	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLG—atherosclerosis	0.000165	0.000529	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000164	0.000529	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PARP1—atherosclerosis	0.000164	0.000526	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GHRL—atherosclerosis	0.000164	0.000526	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLAT—atherosclerosis	0.000164	0.000526	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDN1—atherosclerosis	0.000163	0.000525	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL5—atherosclerosis	0.000162	0.000521	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LPL—atherosclerosis	0.000158	0.00051	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—F2—atherosclerosis	0.000157	0.000505	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	0.000156	0.000501	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000154	0.000495	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP3—atherosclerosis	0.00015	0.000484	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.00015	0.000484	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SPP1—atherosclerosis	0.00015	0.000483	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF2—atherosclerosis	0.00015	0.000482	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	0.000149	0.000481	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOB—atherosclerosis	0.000145	0.000468	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000144	0.000464	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KNG1—atherosclerosis	0.000144	0.000462	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDN1—atherosclerosis	0.000143	0.000461	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000143	0.000459	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL5—atherosclerosis	0.000142	0.000457	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	0.00014	0.00045	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLG—atherosclerosis	0.000139	0.000447	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LPL—atherosclerosis	0.000139	0.000447	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	0.000139	0.000447	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGT—atherosclerosis	0.000135	0.000436	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	0.000135	0.000434	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—atherosclerosis	0.000133	0.000427	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—atherosclerosis	0.000133	0.000427	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000132	0.000424	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—atherosclerosis	0.000132	0.000423	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SPP1—atherosclerosis	0.000132	0.000423	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOA1—atherosclerosis	0.000131	0.000422	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	0.000131	0.000421	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP3—atherosclerosis	0.000127	0.000409	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—atherosclerosis	0.000127	0.000408	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF2—atherosclerosis	0.000127	0.000407	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—F2—atherosclerosis	0.000125	0.000403	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOB—atherosclerosis	0.000123	0.000396	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000122	0.000392	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	0.000122	0.000392	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDN1—atherosclerosis	0.000121	0.000389	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL5—atherosclerosis	0.00012	0.000386	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	0.00012	0.000386	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGT—atherosclerosis	0.000119	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LPL—atherosclerosis	0.000117	0.000378	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—atherosclerosis	0.000116	0.000375	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—atherosclerosis	0.000116	0.000375	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—atherosclerosis	0.000115	0.000371	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA1—atherosclerosis	0.000115	0.00037	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	0.000115	0.000369	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000114	0.000367	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—atherosclerosis	0.000113	0.000365	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—atherosclerosis	0.000112	0.000359	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SPP1—atherosclerosis	0.000111	0.000358	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—atherosclerosis	0.000111	0.000358	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000111	0.000356	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—F2—atherosclerosis	0.00011	0.000353	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—atherosclerosis	0.00011	0.000353	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	0.000105	0.000338	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	0.000104	0.000335	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	0.000103	0.000331	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	0.000101	0.000324	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGT—atherosclerosis	0.0001	0.000323	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—atherosclerosis	9.94e-05	0.00032	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—atherosclerosis	9.94e-05	0.00032	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—atherosclerosis	9.84e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—atherosclerosis	9.84e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—atherosclerosis	9.78e-05	0.000315	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—atherosclerosis	9.75e-05	0.000314	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA1—atherosclerosis	9.72e-05	0.000313	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—atherosclerosis	9.62e-05	0.00031	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—atherosclerosis	9.39e-05	0.000302	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—F2—atherosclerosis	9.28e-05	0.000299	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	9.13e-05	0.000294	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	8.88e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	8.82e-05	0.000284	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—atherosclerosis	8.72e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	8.52e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	8.5e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—atherosclerosis	8.4e-05	0.00027	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—atherosclerosis	8.39e-05	0.00027	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—atherosclerosis	8.27e-05	0.000266	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—atherosclerosis	8.13e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—atherosclerosis	7.98e-05	0.000257	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	7.89e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	7.76e-05	0.00025	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	7.74e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	7.74e-05	0.000249	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	7.72e-05	0.000248	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	7.47e-05	0.00024	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—atherosclerosis	7.37e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—atherosclerosis	7.36e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	7.16e-05	0.000231	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—atherosclerosis	7.09e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—atherosclerosis	7e-05	0.000225	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	6.92e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	6.8e-05	0.000219	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	6.79e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	6.78e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	6.58e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	6.54e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	6.32e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	6.28e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—atherosclerosis	6.22e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—atherosclerosis	6.22e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	5.94e-05	0.000191	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—atherosclerosis	5.91e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	5.85e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	5.77e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	5.75e-05	0.000185	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	5.74e-05	0.000185	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	5.31e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—atherosclerosis	5.26e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	5.02e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—atherosclerosis	4.96e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	4.87e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—atherosclerosis	4.57e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—atherosclerosis	4.35e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—atherosclerosis	4.01e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—atherosclerosis	3.67e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—atherosclerosis	3.39e-05	0.000109	CbGpPWpGaD
